Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
BJU International|May 12, 2006
Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturiaVictor W Nitti, Roger Dmochowski, Rodney A Appell, et al.Neurourology and Urodynamics|June 8, 2012
LUTS patient reported outcomes tool: linguistic validation in 10 European languagesBarbara A Brandt, Çolpan Angün, Karin S Coyne, et al.Journal of the American Geriatrics Society|July 2, 2011
Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms studyChris C Sexton, Karin S Coyne, Christine Thompson, et al.The Canadian Journal of Urology|August 26, 2010
Effects of combined behavioral intervention and tolterodine on patient-reported outcomesJean F Wyman, Carl Klutke, Kathryn Burgio, et al.JAMA|November 16, 2006
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trialSteven A Kaplan, Claus G Roehrborn, Eric S Rovner, et al.International Urogynecology Journal and Pelvic Floor Dysfunction|August 8, 2008
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active womenRebecca Rogers, Gloria Bachmann, Zhanna Jumadilova, et al.European Urology|June 28, 2008
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate sizeClaus G Roehrborn, Steven A Kaplan, J Stephen Jones, et al.Urology|September 27, 2008
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OABClaus G Roehrborn, Steven A Kaplan, Stephen R Kraus, et al.The Journal of Urology|July 22, 2008
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptomsEric S Rovner, Karl Kreder, David O Sussman, et al.BJU International|November 17, 2009
Predictors of discontinuing overactive bladder medicationsLinda Brubaker, Kristina Fanning, Erica L Goldberg, et al.Pageof 6